Article
Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
The Journal of asthma : official journal of the Association for the Care of Asthma - 1 May 2010
Berger William E, Noonan Michael J
Abstract excerpt
OBJECTIVE: Budesonide/formoterol inhalation aerosol (Symbicort AstraZeneca, Wilmington, Delaware) is an inhaled corticosteroid (ICS) and long-acting beta(2)-adrenergic agonist (LABA) combination administered twice daily via one hydrofluoroalkane pressurized metered-dose inhaler (pMDI) approved in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.